Drug profile · INN
treprostinil
TREPROSTINIL SCIPHARM SÀRL
treprostinil (TREPROSTINIL SCIPHARM SÀRL) is a prostanoid ip receptor agonist. Associated with United Therapeutics Europe Ltd. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — treprostinil
- US status
- approved
- Class
- Blood and blood forming organs (B01)
- Route
- INHALATION
- Patents
- 20
- Programs
- 43
- Data quality
- 0.89
Quick answer
treprostinil (TREPROSTINIL SCIPHARM SÀRL) is a prostanoid ip receptor agonist. Associated with United Therapeutics Europe Ltd. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostanoid IP receptor agonist
Primary target: Prostacyclin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12357599
Prodrugs of treprostinil
granted -
US 12173021
Treprostinil prodrugs
granted -
US 12168071
Treprostinil derivatives and their use in pharmaceutical compositions
granted -
US 11826327
Treatment for interstitial lung disease
granted -
US 11826328
Stable treprostinil prodrugs
granted -
US 11723887
Process to prepare treprostinil, the active ingredient in Remodulin®
granted -
US 11672775
Treprostinil prodrugs
granted -
US 11634443
Treprostinil prodrugs
granted -
US 11571444
Enhancement of MSC immunomodulatory properties by treprostinil
granted -
US 11357782
Treprostinil administration by inhalation
granted -
US 11236035
Salts of treprostinil
granted -
US 10716793
Treprostinil administration by inhalation
granted -
US 10695308
Inhalation formulations of treprostinil
granted -
US 10548863
Process to prepare treprostinil, the active ingredient in Remodulin®
granted -
US 10478410
Process to prepare treprostinil, the active ingredient in Remodulin®
granted -
US 10376525
Treprostinil administration by inhalation
granted -
US 10322099
Process to prepare treprostinil, the active ingredient in remodulin®
granted -
US 10167247
Solid forms of treprostinil
granted -
US 10076505
Inhalation formulations of Treprostinil
granted -
US 9988334
Salts of treprostinil
granted
Frequently asked questions
What is treprostinil?
treprostinil (TREPROSTINIL SCIPHARM SÀRL) is a prostanoid ip receptor agonist. Associated with United Therapeutics Europe Ltd. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for treprostinil?
TREPROSTINIL SCIPHARM SÀRL is a marketed brand name for treprostinil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of treprostinil?
treprostinil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.